Results 81 to 90 of about 2,101 (161)

Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination? [PDF]

Rheumatol Adv Pract
Rabee H, Mahto A.
europepmc   +1 more source

Filgotinib for the Treatment of Small Bowel Crohn’s Disease: The DIVERGENCE 1 Trial

Gastroenterology, 2023
D'Haens, Geert R., Lee, Scott, Taylor, Stuart A., Serone, Adrian, Rimola, Jordi, Colombel, Jean-Frederic, Besuyen, Robin, Gecse, Krisztina, McKevitt, Matt, Reinisch, Walter, Ren, Xuehan, Schwartz, David   +11 more
openaire   +2 more sources

Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis. [PDF]

Front Pharmacol
Wu H, Zhou Y, Chen X, Wang L, Guo Y, Du X, Miao X.   +6 more
europepmc   +1 more source

The JAK1-STAT1 signaling pathway triggers inflammation responses in chronic obstructive sleep apnea rat model. [PDF]

PLoS One
Yang L, He J.
europepmc   +1 more source

Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study. [PDF]

Crohns Colitis 360
Matsuoka K, Hata E, Kaise T, Rudolph C, Hibi T.   +4 more
europepmc   +1 more source

Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis. [PDF]

Cureus
Ahmad F, Hussain T, Gunaratne CH, Collum J, Ghaffar A, Gharbia K.   +5 more
europepmc   +1 more source

Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study. [PDF]

World J Gastroenterol
Caballero-Mateos AM, Trigo-Salado C, Suárez-Toribio Á, Martín-Rodríguez MDM, Rodríguez-González FJ, Valdés-Delgado T, Pallarés-Manrique H, Trapero-Martínez AM, Olmedo-Martín R, Bailón-Gaona C, Benitez Cantero JM, Gros B, Sáez-Díaz A, Hernández-Martínez Á.   +13 more
europepmc   +1 more source

Filgotinib in Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis of Efficacy and Adverse Events. [PDF]

Healthcare (Basel)
Khoshaim YA, Habis YZ, Daqnah AG, Alqurashi RK, Abdulrahim YS, Sakkat A, Alsubhi SA, Almuwlad DT, Bukhari HS, Shogdar AJ, Amir OA, Zaazouee MS.   +11 more
europepmc   +1 more source

Revisiting Janus kinases as molecular drug targets for rheumatic diseases. [PDF]

Front Med (Lausanne)
Kwon S.
europepmc   +1 more source

Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry. [PDF]

United European Gastroenterol J
Naber MR, van der Meulen AE, Voorneveld PW, Veltkamp SHC, van Bodegraven AA, Bodelier A, Mujagic Z, Pierik M, Verleye LMM, Duijvestein M, Bouwknegt DG, Visschedijk MC, Srivastava N, West RL, Oldenburg B, Löwenberg M, van Schaik FDM, Dutch ICC Registry.   +17 more
europepmc   +1 more source